The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
Sponsor: Brigham and Women's Hospital
Terminated
The study stopped due to lack of funding.
Other terminated trials from Brigham and Women's Hospital
Listed as NCT01238588, this NA trial focuses on Atherosclerosis and Cardiovascular Disease and remains terminated or withdrawn. Sponsored by Brigham and Women's Hospital, it has been updated 8 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Sep 2017 — Jun 2018 [monthly]
Terminated NA
-
Aug 2017 — Sep 2017 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .